MarketStudyReport.com adds “Global D-Biotin (Vitamin H) Market Outlook 2016-2021” new report to its research database. The report spread across 94 pages with table and figures in it.
It is composed of a ureido (tetrahydroimidizalone) ring fused with a tetrahydrothiophene ring. A valeric acid substituent is attached to one of the carbon atoms of the tetrahydrothiophene ring. Biotin is a coenzyme for carboxylase enzymes, involved in the synthesis of fatty acids, isoleucine, and valine, and in gluconeogenesis.
Biotin deficiency can be caused by inadequate dietary intake or inheritance of one or more inborn genetic disorders that affect biotin metabolism (see multiple carboxylase deficiency). Subclinical deficiency can cause mild symptoms, whereas the inborn genetic disorders can have severe (even lethal) consequences. Neonatal screening for biotinidase deficiency began in the United States in 1984 and today many countries test for this disorder at birth. Individuals born prior to 1984 are unlikely to have been screened, thus the true prevalence of the disorder is unknown.
Browse full table of contents and data tables @ https://www.marketstudyreport.com/reports/global-d-biotin-vitamin-h-market-outlook-2016-2021/
Biotin-thiamine-responsive basal ganglia disease is another potentially life-threatening condition that requires biotin (and thiamine, another B vitamin) for treatment.
Claims are made that biotin supplements support hair and nail growth, and so the vitamin is marketed for these indications. The nails data is from three trials without placebo controls, conducted with 2,500 micrograms/day. After six months, nails were thicker and less brittle in about 2/3 of the subjects (Hochman 1993, Colombo 1990, Floersheim 1989).
This report provides detailed analysis of worldwide markets for D-Biotin (Vitamin H) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the D-Biotin (Vitamin H) market and further lays out an analysis of the factors influencing the supply/demand for D-Biotin (Vitamin H), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
GCC’s report, Global D-Biotin (Vitamin H) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global D-Biotin (Vitamin H) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global D-Biotin (Vitamin H) market are DSM (Netherlands), Zhejiang Medicine (China), Shengda Bio-pharm (China), Hengo (China), Kexing Biochem (China), among others.
To receive personalized assistance, write to us @ firstname.lastname@example.org with the report title in the subject line along with your questions or call us at +1 866-764-2150